Reveal more with low-dose, highly accurate 3D Mammography™ exams

The Selenia® Dimensions® Mammography System with C-View™ Software

C-View™ Software – obtain high quality images while minimising patient radiation and discomfort

Raise your breast cancer screening performance1-7 with C-View™ Software and instantly generated synthesised 2D images. While enabling you to enhance details and speed analysis, you will also reduce radiation dose levels for your patient.

C-View™ 2D images are clinically proven and FDA approved to diagnostically replace the FFDM images within a tomosynthesis screening exam.

C-View™ Software – obtain high quality images while minimising patient radiation and discomfort
See more, do more

See more, do more

Architectural distortions, mass lesions, and bright spots commonly found in microcalcifications are more visible in the C-View™ 2D image than on the traditional FFDM 2D images or tomo slices.

Low dose 3D Mammography™ exams are proven to find invasive cancer earlier vs 2D alone,5,7-9 while also reducing false positive recall rates5,7-11

Delivers superior clinical performance vs 2D mammography alone for all breast types5,7-12

Reduces the risk of retakes with ultra-fast 3.7-second scans5,7-12

Greater accuracy at a lower dose5,7,10,12,13

C-View™ 2D imaging is a purchasable option available on both Selenia® Dimensions® and 3Dimensions™ systems. It is compatible with standard resolution 3D™ imaging only. It is not compatible with high-resolution 3D™ imaging.

  1. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.,
  2. Rafferty EA, Durand MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts. JAMA. 2016;315(16): 1784-6.
  3. Data on file and from public sources, 2017
  4. Data On File: DHM-06039 Rev 002 Jennifer Bartoshevich, Teri Orefice, Sajjad Mansoor, Internal Study comparing Hologic®’s flat paddle to the SmartCurve™ paddle (18x24cm) (2017).
  5. FDA submissions P080003, P080003/S001 P080003/S0056.
  6. Smith A. Improving patient comfort in mammorgraphy. WP-00119 Rev 003 (11/17). Available at
  7. Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.
  8. Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun;271(3):655-63.
  9. Patel BK., et al, Potential Cost Savings of Contrast-Enhanced Digital Mammography. AJR Apr 2017.
  10. Breast MRI - Available at: (Accessed in Dec 2019)
  11. Berg, W.A., et al, Reasons Women at Elevated Risk of Breast Cancer Refuse Breast MR Imaging Screening: ACRIN 6666, Radiology Jan 2010.
  12. Phillips J, et al. Contrast-enhanced spectral mammography (CESM) versus MRI in the high-risk screening setting: patient preferences and attitudes. Clin Imaging. Mar – Apr 2017.
  13. Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730-736
ce mark
0050 TruNode® 2797 All Other Products
Hologic BV, DA Vincilaan 5,
1930 Zaventem, Belgium

Product Notice

You are about to access medical systems information on the Hologic 3Dimensions™ Mammography System European Website. Product availability differs by region and country and is subject to varied regulatory requirements.

The content of this site is reserved for Health Care Professionals only.

I am a Health Care Professional or similar.

Je suis un professionnel de santé ou assimilé.

Je ne suis pas un professionnel de santé ou assimilé.